Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2787-2790

  Degeorges, Armelle ^a   Wang, Fuan ^a   Frierson Jr , Henry F ^a   Seth, Arun ^b   Chung, Leland W K ^a   Sikes, Robert A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN;

ARTICLE; BINDING AFFINITY; CANCER CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; TARGET ORGAN;

CARRIER PROTEINS; COHORT STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033564798     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Murphy, M., Pykett, M. J., Harnish, P., Zang, K. D., and George, D. L. Identification and characterization of genes differentially expressed in meningiomas. J. Clin. Endocrinol. Metab., 4: 715-722, 1993.
2. Swisshelm, K., Ryan, K., Tsuchiya, K., and Sager, R. Enhanced expression of an insulin growth factor-like binding protein (mac 25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc. Natl. Acad. Sci. USA, 92: 4472-4476, 1995.
3. Oh, Y., Nagalla, S. R., Yamanaka, Y., Kim, H. S., Wilson, E., and Rosenfeld, R. G. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. J. Biol. Chem., 271: 30322-30325, 1996.
4. Baxter, R., Binoux, M., Clemmons, D., Conover, C., Drop, S., Holly, S., Mohan, S., Oh, Y., and Rosenfeld, R. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology, 139: 4036, 1998.
5. Burger, A. M., Zhang, X., Li, H., Ostrowski, J. L., Beatty, B., Venanzoni, M., Papas, T., and Seth, A. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene is associated with disease progression in breast carcinomas. Oncogene, 16: 2459-2467, 1998.
6. Tennant, M. K., Trasher, J. B., Twomey, P. A., Birnbaum, R. S., and Plymate, S. R. Insulin-like growth factor-binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J. Clin. Endocrinol. Metab., 81: 3783-3792, 1996.
7. Tennant, M. K., Trasher, J. B., Twomey, P. A., Birnbaum, R. S., and Plymate, S. R. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. J. Clin. Endocrinol. Metab., 81: 411-420, 1996.
8. Figueroa, J. A., De Raad, S., Tadlock, L., Speights, V. O., and Rinehart, J. J. Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer. J. Urol., 159: 1379-1383, 1998.
9. Chang, S. M., and Chung, L. W. K. Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology, 125: 2719-2727, 1989.
10. Thalmann, G. N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pahak, S., von Eschenbach, A. C., and Chung, L. W. K. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res., 54: 2577-2581, 1994.
11. Ozen, M., Multani, A. S., Chang, S., Von Eschenbach, A. C., Chung, L. W. K., and Pathak, S. Establishment of an in vitro cell model system to study human prostate carcinogenesis: involvement of chromosome 5 in early stages of neoplastic transformation. Int. J. Oncol., 8: 883-888, 1996.
12. Theodorescu, D., Broder, S. R., Boyd, J. C., Mills, S. E., and Frierson, H. F. J. p53, bcl-2, and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate. J. Urol., 158: 131-137, 1997.
13. Wu, T. T., Sikes, R. A., Cui, Q., Thalmann, G. N., Kao, C., Murphy, C. F., Yang, H., Zhau, H. E., Balian, G., and Chung, L. W. K. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by PSA-producing tumors in athymic and SC1D/bg mice using LNCaP and lineage-derived metastatic sublines. Int. J. Cancer, 77: 887-894, 1998.
14. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
15. Sikes, R. A., and Chung, L. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Res., 52: 3174-3181, 1992.
16. Pietrzkowski, Z., Mulholland, G., Gomella, L., Jameson, B. A., Wernicke, D., and Baserga, R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor. Cancer Res., 53: 1102-1106, 1993.
17. Figueroa, J. A., Lee, A. V., Jackson, J. G., and Yee, D. Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop. J. Clin. Endocrinol. Metab., 80: 3476-3482, 1995.
18. Cohen, P., Peehl, D. M., Baker, B., Liu, F., Hintz, R. L., and Rosenfeld, R. G. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J. Clin. Endocrinol. Metab., 79: 1410-1415, 1994.
19. Thrasher, J. B., Tennant, M. K., Twomey, P. A., Hansberry, K. L., Wettlaufer, J. N., and Plymate, S. R. Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: clinical correlations. J. Urol., 155: 999-1003, 1996.
20. Hwa, V., Tomasini-Sprenger, C., Bermejo, A., Rosenfeld, R., and Plymate, S. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells. J. Clin. Endocrinol. Metab., 83: 4355-4362, 1998.
21. Yamanaka, Y., Wilson, E. M., Rosenfeld, R. G., and Oh, Y. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J. Biol. Chem., 272: 30729-30734, 1997.
22. Rajah, R., Valentinis, B., and Cohen, P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem., 272: 12181-12188, 1997.
23. Leal, S. M., Liu, Q. L., Huang, S. S., and Huang, J. S. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem., 272: 20572-20576, 1997.
24. Koivisto, P., Kononen, J., Palmberg, C., Tammela, T., Hyytinen, E., Isola, J., Trapman, J., Cleutjens, K., Noordzij, A., Visakorpi, T., and Kallioniemi, O. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res., 57: 314-319, 1997.
25. Brothman, A., Peehl, D., Patel, A., and McNeal, J. Frequency and pattern of karyotypic abnormalities on human prostate cancer. Cancer Res., 50: 3795-3803, 1990.
26. Jarrard, D., Kinoshita, H., Shi, Y., Sandefur, C., Hoff, D., Meisner, L., Chang, C., Herman, J., Isaacs, W., and Nassif, N. Methylation of the androgen receptor promoter CpG islands is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Res., 58: 5310-5314, 1998.
27. Martin, V., Ribieras, S., Song-Wang, X., Lasne, Y., Frappart, L., Rio, M., and Dante, R. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers. J. Cell. Biochem., 65: 95-106, 1998.
28. Birger, Y., Shemer, R., Perk, J., and Razin, A. The imprinting box of the mouse Igf2r gene. Nature (Lond.), 397: 84-88, 1999.